Nurix Therapeutics, Inc.
Industry: Life Sciences ・ $NRIX on Nasdaq
Insider Sale
+$83,519
-6.35%
Shares
Shares Volume: 3,437 Shares
Average Share Price: $24.3
INSIDER
Hansen Gwenn
Chief Scientific Officer (Officer)
reported on Oct 30 2024
traded on Oct 30 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 50,670 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $49,193.85 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 28 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $97,972.95 |
| COMPANY PREVIOUS TRADES |